Related Experiment Video
Updated: Feb 27, 2026
08:57
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
2.7K
[Clinical and Pathologic Features of Myeloid Sarcoma]
Ya-Jun Jiang1, Hong-Xia Wang2, Wan-Chuan Zhuang1
1Department of Hematology, The Second People's Hospital of Lianyungang City, Lianyungang 222000, Jiangsu Province, China.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
|June 24, 2017
Summary
Myeloid sarcoma, a rare cancer, presents diverse clinicopathologic features. Accurate diagnosis relies on pathology and immunohistochemistry, with chemotherapy and stem cell transplant as key treatments.
Area of Science:
- Hematology
- Oncology
- Pathology
Background:
- Myeloid sarcoma is an extramedullary tumor of myeloid blasts.
- It can occur de novo or secondary to other myeloid neoplasms.
- Understanding its features is crucial for timely diagnosis and treatment.
Purpose of the Study:
- To investigate the clinicopathologic characteristics of myeloid sarcoma.
- To outline differential diagnostic considerations.
- To review therapeutic strategies for myeloid sarcoma.
Main Methods:
- Retrospective analysis of clinical data from 10 myeloid sarcoma patients.
- Inclusion of clinical manifestations, laboratory tests, histopathology, and immunohistochemistry.
- Evaluation of clinical prognosis and treatment outcomes.
Main Results:
- Neoplasms occurred in various sites including bone, brain, skin, and lymph nodes.
- Immunohistochemistry confirmed myeloid origin (MPO, CD34, CD45, CD117 positive).
- Four patients progressed to acute myeloid leukemia; treatment outcomes varied, with some relapsing.
Conclusions:
- Myeloid sarcoma diagnosis requires differentiation from lymphomas and other neoplasms.
- Pathological and immunohistochemical findings are essential for accurate diagnosis.
- Chemotherapy and allogeneic hematopoietic stem cell transplantation are primary treatment modalities.
Related Concept Videos
01:15Differentiation of Common Myeloid Progenitor Cells
4.1K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.1K
02:23Abnormal Proliferation
5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K